510(k) · Cleared
ClearedOdfs Pace
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Odstock Medical, Ltd. · GZI Stimulator, Neuromuscular, External Functional
Cleared on Mar 30, 2011 as substantially equivalent to K951951 (Empi, 1996) and 1 other predicate after a 245-day review. Its family tree reaches back 3 generations to 1980. 16 later devices descend from it.
- Decided
- Mar 30, 2011
- Review
- 245 days
- Class
- Class II
- Product code
- GZI
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 3 generations to K800380 (1980). 7 ancestors in all. 16 later devices descend from it, 2 citing it directly.
- Root · 3 generations backK800380 Fes Orthosis Model NO. 2000Empi · 1980
- 2 generations backK974514 External Functional Neuromuscular StimulatorNeuromotion, Inc. · 1998
- 1 generation backK050991 The Odfs Dropped Foot StimulatorDepartment of Medical Physics and Biomedical Eng. · 2005
- This deviceK102115 Odfs PaceOdstock Medical, Ltd. · 2011
- Descendant · cites it directly · 14 of its ownK123972 Walkaide SystemInnovative Neurotronics, Inc. · 2013
- Descendant · 2 generations on · 10 of its ownK140886 Walkaide SystemInnovative Neurotronics, Inc. · 2014
- Descendant · 3 generations on · 9 of its ownK162407 L300 Go SystemBioness, Inc. · 2017
- Descendant · 4 generations on · 7 of its ownK173682 L300 Go SystemBioness, Inc. · 2018
- Descendant · 5 generations on · 5 of its ownK190285 L300 Go SystemBioness, Inc. · 2019
Showing 5 of 16 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 16 · See all- K123972Walkaide SystemInnovative Neurotronics, Inc. · 2013 · cites it directly14descendants
- K140886Walkaide SystemInnovative Neurotronics, Inc. · 2014 · 2 generations on10descendants
- K162407L300 Go SystemBioness, Inc. · 2017 · 3 generations on9descendants
- K173682L300 Go SystemBioness, Inc. · 2018 · 4 generations on7descendants
- K190285L300 Go SystemBioness, Inc. · 2019 · 5 generations on5descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −3 | K800380 | Fes Orthosis Model NO. 2000 | Empi | 1980 | — |
| −2 | K974514 | External Functional Neuromuscular Stimulator | Neuromotion, Inc. | 1998 | — |
| −1 | K050991 | The Odfs Dropped Foot Stimulator | Department of Medical Physics and Biomedical Eng. | 2005 | — |
| 0 (this device) | K102115 | Odfs Pace | Odstock Medical, Ltd. | 2011 | — |
| +1 | K123972 | Walkaide System | Innovative Neurotronics, Inc. | 2013 | — |
| +2 | K140886 | Walkaide System | Innovative Neurotronics, Inc. | 2014 | — |
| +3 | K162407 | L300 Go System | Bioness, Inc. | 2017 | — |
| +4 | K173682 | L300 Go System | Bioness, Inc. | 2018 | — |
| +5 | K190285 | L300 Go System | Bioness, Inc. | 2019 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1982 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1996 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2013 | 1 | 0 |
| 2014 | 1 | 0 |
| 2015 | 1 | 0 |
| 2017 | 2 | 0 |
| 2018 | 2 | 0 |
| 2019 | 2 | 0 |
| 2020 | 2 | 0 |
| 2021 | 1 | 0 |
| 2022 | 2 | 0 |
| 2023 | 1 | 0 |
| 2025 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in GZI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new GZI device
- #1 K243828 Cionic Neural Sleeve (NS-200)score 12.9 · 13 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
What descends from it? (16)
See all 162 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 31 years and passes through 4 companies; a new generation was cleared every 7.4 years on median.
- None of the 7 ancestors has a recall.
- Of its descendants, K123972 (Innovative Neurotronics, Inc., 2013) has gone furthest, with 14 descendants of its own.
- 5 other devices also cite its predicate K951951.
How does its category compare?
All GZI devicesGZI Stimulator, Neuromuscular, External Functional: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.
FDA decisions per year · GZI
2in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · GZI
110in 2022
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · GZI
1in 2008
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · GZI
3in 2025
MAUDE reports naming product code GZI, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 4 | 81 | 0 | 1 |
| 2008 | 1 | — | 1 | 2 |
| 2009 | 1 | — | 0 | 8 |
| 2010 | 0 | — | 0 | 1 |
| 2011 | 6 | 139 | 0 | 3 |
| 2012 | 2 | — | 0 | 2 |
| 2013 | 2 | — | 0 | 0 |
| 2014 | 3 | 299 | 0 | 2 |
| 2015 | 1 | — | 0 | 3 |
| 2016 | 1 | — | 0 | 0 |
| 2017 | 6 | 168 | 0 | 2 |
| 2018 | 2 | — | 0 | 1 |
| 2019 | 2 | — | 0 | 4 |
| 2020 | 2 | — | 0 | 0 |
| 2021 | 1 | — | 0 | 1 |
| 2022 | 4 | 110 | 0 | 3 |
| 2023 | 1 | — | 0 | 1 |
| 2024 | 2 | — | 0 | 1 |
| 2025 | 2 | — | 0 | 3 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The ODES® Pace is intended to provide ankle dorsiflexion in individuals who have a dropped foot as a consequence of upper motor neuron injury. By detecting the swing phase of gait through a foot switch signal, appropriate electrical stimulation of the leg and ankle muscles may improve gait by flexing the foot of persons who have lost or impaired function. There may be additional benefits from FES such as muscle re-education, prevention/retardation of…
Read the full statement (115 words)
The ODES® Pace is intended to provide ankle dorsiflexion in individuals who have a dropped foot as a consequence of upper motor neuron injury. By detecting the swing phase of gait through a foot switch signal, appropriate electrical stimulation of the leg and ankle muscles may improve gait by flexing the foot of persons who have lost or impaired function. There may be additional benefits from FES such as muscle re-education, prevention/retardation of disuse atrophy, increased or maintained range of joint motion and increase in local blood flow.
The ODES® Pace is a medical device and should only be used under medical supervision for the treatment of dropped foot following an upper motor neuron injury.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K102115 · printed Nov 6, 2026
Cite this page
510(k) Report. “K102115: Odfs Pace.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K102115
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026